Capital Expenditures for McKesson (MCK)
According to McKesson's latest reported financial statements, the company's current capital expenditures (TTM) is $608.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MCK
Currently viewingCapital ExpendituresSwitch metric
Latest period
$608.00M
YoY change
+25.0%
5Y CAGR
+11.2%
Peak year (1997)
$1.29B
Cumulative capital expenditures
$12.99B
CapEx history chart for McKesson (MCK) from 1995 to 2025
CapEx history table for McKesson (MCK) from 1995 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $859.00M | +25.0% | ||
| 2024 | $687.00M | +23.1% | ||
| 2023 | $558.00M | +4.3% | ||
| 2022 | $535.00M | -16.5% | ||
| 2021 | $641.00M | +26.7% | ||
| 2020 | $506.00M | -9.2% | ||
| 2019 | $557.00M | -4.0% | ||
| 2018 | $580.00M | +3.2% | ||
| 2017 | $562.00M | -17.0% | ||
| 2016 | $677.00M | +24.2% | ||
| 2015 | $545.00M | +31.3% | ||
| 2014 | $415.00M | +2.2% | ||
| 2013 | $406.00M | +0.7% | ||
| 2012 | $403.00M | +3.9% | ||
| 2011 | $388.00M | +2.6% | ||
| 2010 | $378.00M | -3.6% | ||
| 2009 | $392.00M | +10.1% | ||
| 2008 | $356.00M | +16.3% | ||
| 2007 | $306.00M | +83.2% | ||
| 2006 | $167.00M | +19.4% | ||
| 2005 | $139.90M | +21.7% | ||
| 2004 | $115.00M | -0.9% | ||
| 2003 | $116.00M | -12.0% | ||
| 2002 | $131.80M | -17.1% | ||
| 2001 | $158.90M | +9.5% | ||
| 2000 | $145.10M | -73.8% | ||
| 1999 | $553.40M | +138.1% | ||
| 1998 | $232.40M | -81.9% | ||
| 1997 | $1.29B | +1061.0% | ||
| 1996 | $110.80M | +34.6% | ||
| 1995 | $82.30M | — |
CapEx values are taken from McKesson's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, McKesson (MCK) reported capital expenditures of $859.00M – grew 25.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, McKesson capital expenditures compounded at +11.2% per year, sustaining 3 straight years of year-over-year growth.
McKesson capital expenditures peaked at $1.29B in 1997; the latest annual figure is $859.00M in 2025 (33.2% below peak).
1997 marks the peak capital expenditures at $1.29B, with the historical low of $82.30M recorded in 1995.
Among 8 Healthcare peers, McKesson (MCK) ranks 9th; the peer median for capital expenditures is $3.87B.
McKesson Capital Expenditures by Year
McKesson Capital Expenditures 2025: $859.00M
McKesson capital expenditures in 2025 was $859.00M, grew 25.0% from 2024.
McKesson Capital Expenditures 2024: $687.00M
McKesson capital expenditures in 2024 was $687.00M, grew 23.1% from 2023.
McKesson Capital Expenditures 2023: $558.00M
McKesson capital expenditures in 2023 was $558.00M, edged up 4.3% from 2022.
McKesson Capital Expenditures 2022: $535.00M
McKesson capital expenditures in 2022 was $535.00M, declined 16.5% below 2021.
McKesson Capital Expenditures 2021: $641.00M
McKesson capital expenditures in 2021 was $641.00M.
See more financial history for McKesson (MCK).
Sector peers — CapEx
Companies in the same sector as McKesson, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is McKesson's capital expenditures?
- Latest reported capital expenditures for McKesson (MCK) is $608.00M (period ending December 31, 2025).
How has McKesson capital expenditures changed year-over-year?
- McKesson (MCK) capital expenditures changed +25.0% year-over-year on the latest annual filing.
What is the long-term growth rate of McKesson capital expenditures?
- McKesson (MCK) capital expenditures compound annual growth rate is +11.2% over the most recent 5 years available.
When did McKesson capital expenditures hit its highest annual value?
- McKesson capital expenditures reached its highest annual value of $1.29B in 1997.
What was McKesson capital expenditures in 2024?
- McKesson (MCK) capital expenditures in 2024 was $687.00M.
What was McKesson capital expenditures in 2025?
- McKesson (MCK) capital expenditures in 2025 was $859.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MCK Overview
Company profile, financial tools, and key metrics
MCK Revenue Counter
Earns $12,619 every second. See per minute, hour, and day.
MCK Earnings Counter
Earns $137.62 per second net profit. See per minute, hour, and day.
MCK Economic Scale
Exceeds Egypt, Arab Rep.'s GDP. Compare with world economies.
MCK What If Invested
What if you had invested $1,000? See historical returns from any date.
MCK How It Makes Money
Discover visual breakdown of $397.96B in revenue — where it comes from and where it goes.
MCK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MCK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MCK Daily Price Character
Steady · 51.5% historical win rate (green days). Streaks & record days.
MCK Buybacks
2.12% TTM buyback yield. Shareholder yield & SBC comparison.
MCK Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
MCK Dividend Profile
Yield: 0.39%. Safety: 8/8. See full history.
MCK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MCK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.